Switching medicines safely If a doctor decides a new treatment is the right step, the change is usually made slowly
The global conversation around obesity and metabolic disease has shifted rapidly in recent years
Now the FDA has pulled the warning that started it
Semaglutide reduces severity of common liver disease in people with
The Molecular Targets Driving the Revolution Modern incretin-based therapies harness three key hormone receptors that work together to regulate glucose metabolism, appetite, and energy balance: GLP-1R (Glucagon-Like Peptide-1 Receptor) Activated by drugs such as Semaglutide , this receptor stimulates insulin secretion, slows gastric emptying, and promotes satiety, helping reduce food intake and improve blood glucose control
At our clinic, we take the time to understand your lifestyle and tailor every aspect of your care to you